DrugDashboards

Epinephrine

Epinephrine · EPINEPHRINE 1 mg/mL · Injection, Solution, Concentrate · Intramuscular; Intraocular; Intravenous; Subcutaneous · BPI Labs, LLC

NDC 54288-0103-10 · 10 AMPULE in 1 BOX / 1 mL in 1 AMPULE · NDA · View full market →

The short version

11 companies supply this market — deep enough that no single failure threatens the supply. Historically, drugs in this position went on to a new shortage within 90 days about 0.5% of the time — roughly 4× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.5%chance of a new FDA shortage posting for epinephrine (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 4× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $206.21 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA205029
TE code
AP
Approval date
Jul 29, 2014
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Epinephrine (Injection, Solution, Concentrate)

LabelerStrengthFirst seenLast seen
Baxter Healthcare CorporationEPINEPHRINE 1 mg/mLJul 15, 2026Sep 3, 2026
A-S Medication SolutionsEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
BPI Labs, LLCEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Civica, Inc.EPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., UsaEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.EPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
ProPharma DistributionEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Remedyrepack Inc.EPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCEPINEPHRINE 1 mg/mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Epinephrine — NDC 54288-0103-10," retrieved September 3, 2026, https://drugdashboards.com/drug/54288010310.

Free to cite with attribution — see how the data is put together.